Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation. (Q34389439)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Marco Cattaneo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

M Bäck

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

D J Angiolillo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

K S Sakariassen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

1 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Haemostasis

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

126-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24298905%20AND%20SRC:MED&resulttype=core&format=json

Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) alpha and beta isoforms

2 March 2020

cites work

1 reference

Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan

21 January 2018

1 reference

Low-dose aspirin for the prevention of atherothrombosis

21 January 2018

1 reference

Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser light scattering to assess platelet aggregability

21 January 2018

1 reference

Platelet activation in type 2 diabetes mellitus

21 January 2018

1 reference

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

21 January 2018

1 reference

Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species

21 January 2018

1 reference

Prostanoid and isoprostanoid pathways in atherogenesis

21 January 2018

1 reference

TP receptor antagonism: a new concept in atherothrombosis and stroke prevention

21 January 2018

1 reference

Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases

21 January 2018

1 reference

From the design to the clinical application of thromboxane modulators

21 January 2018

1 reference

Thromboxane A2 receptor: biology and function of a peculiar receptor that remains resistant for therapeutic targeting.

21 January 2018

1 reference

Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.

21 January 2018

1 reference

Differential regulation of RhoA-mediated signaling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: independent modulation of TPalpha signaling by prostacyclin and nitric oxide.

21 January 2018

1 reference

Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology

21 January 2018

1 reference

G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets

21 January 2018

1 reference

Defective platelet activation in G alpha(q)-deficient mice.

21 January 2018

1 reference

Unresponsiveness of platelets lacking both Galpha(q) and Galpha(13). Implications for collagen-induced platelet activation

21 January 2018

1 reference

Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2

21 January 2018

1 reference

Abnormal platelet response to thromboxane A2.

21 January 2018

1 reference

Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder

21 January 2018

1 reference

Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation

21 January 2018

1 reference

A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis

21 January 2018

1 reference

Bleeding tendency and impaired platelet function in a patient carrying a heterozygous mutation in the thromboxane A2 receptor.

21 January 2018

1 reference

Platelet dysfunction associated with the novel Trp29Cys thromboxane A₂ receptor variant.

21 January 2018

1 reference

Basic principles of platelet biology and clinical implications

21 January 2018

1 reference

Thromboxane receptors antagonists and/or synthase inhibitors

21 January 2018

1 reference

Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo

21 January 2018

1 reference

Platelet function profiles in patients with diabetes mellitus

21 January 2018

1 reference

TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus.

21 January 2018

1 reference

The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies.

21 January 2018

1 reference

Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study

21 January 2018

1 reference

Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke

21 January 2018

1 reference

Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study

21 January 2018

1 reference

Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers.

21 January 2018

1 reference

Single ascending oral dose pharmacokinetics and pharmacodynamics study of EV-077: the specific inhibitor of prostanoid- and isoprostane-induced cellular activation

21 January 2018

1 reference

Free radicals in the physiological control of cell function

21 January 2018

1 reference

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins

21 January 2018

1 reference

Involvement of NADH/NADPH oxidase in human platelet ROS production

21 January 2018

1 reference

Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress

21 January 2018

1 reference

Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke

21 January 2018

1 reference

The F2-isoprostane 8-epiprostaglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO.

21 January 2018

1 reference

Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors

21 January 2018

1 reference

Beta2 integrin-dependent neutrophil adhesion induced by minimally modified low-density lipoproteins is mainly mediated by F2-isoprostanes

21 January 2018

1 reference

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

21 January 2018

1 reference

Increased formation of distinct F2 isoprostanes in hypercholesterolemia.

21 January 2018

1 reference

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

21 January 2018

1 reference

Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.

21 January 2018

1 reference

Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.

21 January 2018

1 reference

Increased lipid peroxidation in patients with pulmonary hypertension.

21 January 2018

1 reference

Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease

21 January 2018

1 reference

Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension

21 January 2018

1 reference

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

21 January 2018

1 reference

Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability

21 January 2018

1 reference

The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases

21 January 2018

1 reference

Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin

21 January 2018

1 reference

Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin

21 January 2018

1 reference

Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells.

21 January 2018

1 reference

Role of prostacyclin in the cardiovascular response to thromboxane A2

21 January 2018

1 reference

Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis

21 January 2018

1 reference

Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis.

21 January 2018

1 reference

Prostanoid receptors in the human vascular wall.

21 January 2018

1 reference

The contractile action of leukotriene B4 in the guinea-pig lung involves a vascular component.

21 January 2018

1 reference

Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits

21 January 2018

1 reference

Aortic thromboxane receptor deficiency alters vascular reactivity in cholesterol-fed rabbits

21 January 2018

1 reference

Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion

21 January 2018

1 reference

Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: correlation with plaque composition

21 January 2018

1 reference

Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice

21 January 2018

1 reference

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.

21 January 2018

1 reference

Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice

21 January 2018

1 reference

Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient mice

21 January 2018

1 reference

Role of cytochrome P450 metabolites of arachidonic acid in hypertension

21 January 2018

1 reference

Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects.

21 January 2018

1 reference